#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Neuroblastoma Lupus nephritis Hepatitis D Neuroendocrine cell hyperplasia of infancy Anal fistula Intracranial calcification Immune-mediated myositis Medullary thyroid cancer Neurotrophic keratopathy Ureteric cancer Hydrocephalus Pyruvate dehydrogenase complex deficiency Pneumonia Pyruvate kinase deficiency anaemia Hodgkin's disease refractory More trials…

    Learn about Rare Diseases

    SAPHO syndrome – Diagnostics Retinitis pigmentosa – Basic Information Gastrointestinal stromal tumour Osteosarcoma – Treatment Cerebral arteriovenous malformation haemorrhagic – Diagnostics Medulloblastoma recurrent – Trials in Disease Ornithine transcarbamoylase deficiency – Basic Information Retinoblastoma – Life with Disease Glycogen storage disease type II – Life with Disease Chondrosarcoma metastatic – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ursodeoxycholic Acid Nedosiran GSK5784283 Copper (64Cu) Chloride Df6002 Latozinemab Terlipressin Altizide Ampicillin Nortriptyline Hydrochloride Casirivimab Bi 764524 Munc-T3 Vismodegib SELTOREXANT Gskvx000000009151 Azd8630 Betamethasone Acetate Paeonol LINAPRAZAN GLURATE More therapies…

    Learn about Your Condition

    Choroidal neovascularisation Foetal growth restriction Hypoxia Systemic infection Netherton's syndrome Chronic kidney disease Methylmalonic acidaemia Bile acid synthesis disorder Retinitis pigmentosa Haemoptysis Neuroendocrine carcinoma Infertility Post procedural complication Glucose tolerance impaired Acute coronary syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Virus Diseases

  • Study on Montelukast for COVID-19 Patients at Higher Risk in Primary Care

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • COVID-19
    Investigated Drugs:
    • Montelukast
    The Netherlands

  • Study on the Effectiveness of Rilpivirine-Based Treatment for HIV Patients with Metabolic Liver Disease Using Dolutegravir, Rilpivirine, and Emtricitabine/Tenofovir Combination

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • HIV infection
    Investigated Drugs:
    • Dolutegravir Sodium
    • Rilpivirine Hydrochloride
    • Tenofovir Disoproxil Fumarate
    Spain

  • Study Comparing Bictegravir and Lenacapavir to Current Treatment in Patients with HIV-1 on Complex Regimens

    Not recruiting

    4 1 1 1
    Investigated Drugs:
    • Bictegravir
    • Lenacapavir
    • Lenacapavir Sodium
    France Germany Italy Spain

  • Study on the Effects of S-217622 for Adults Hospitalized with COVID-19

    Not recruiting

    3 1
    Investigated Diseases:
    • COVID-19
    Investigated Drugs:
    • (6E)-6-[(6-Chloro-2-Methyl-2H-Indazol-5-Yl)Imino]-3-[(1-Methyl-1H-1,2,4-Triazol-3-Yl)Methyl]-1-[(2,4,5-Trifluorophenyl)Methyl]-1,3,5-Triazinane-2,4-Dione
    Denmark Germany Greece Ireland Poland Spain

  • Study on the Safety and Effects of RBD1016 Injection for Patients with Chronic Hepatitis B on Nucleoside Analogues Treatment

    Not recruiting

    2 1
    Investigated Drugs:
    • Rbd1016
    Sweden

  • Study on Everolimus and Mycophenolate Mofetil for Improving COVID-19 Vaccine Response in Kidney Transplant Patients

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Herpes zoster
    • Renal transplant
    • COVID-19
    Investigated Drugs:
    • Raxtozinameran
    • Mycophenolic Acid
    • Recombinant Varicella Zoster Virus Glycoprotein E
    The Netherlands
Previous Page
1 … 46 47 48 49 50 51
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!